These authors contributed equally.
Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles
Version of Record online: 24 JUN 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 2, pages 508–520, August 2014
How to Cite
Doerrbecker, J., Friesland, M., Riebesehl, N., Ginkel, C., Behrendt, P., Brown, R. J.P., Ciesek, S., Wedemeyer, H., Sarrazin, C., Kaderali, L., Pietschmann, T. and Steinmann, E. (2014), Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles. Hepatology, 60: 508–520. doi: 10.1002/hep.27190
Potential conflict of interest: Dr. Pietschmann consults for Biotest and Janssen.
E.S. was supported by the DFG (STE 1954/1-1) and an intramural young investigator award of the Helmholtz Centre for Infection Research. T.P. was supported by grants from the DFG (PI 734/2-1) and the Helmholtz Association (SO-024) and the i-Med initiative.
- Issue online: 22 JUL 2014
- Version of Record online: 24 JUN 2014
- Accepted manuscript online: 27 APR 2014 03:53AM EST
- Manuscript Accepted: 23 APR 2014
- Manuscript Received: 7 JAN 2014
Additional Supporting Information may be found in the online version of this article at the publisher's website.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.